Benjamin Edwards Inc’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,068
Closed -$55K 703
2023
Q1
$55K Buy
1,068
+629
+143% +$30.5K 0.01% 449
2022
Q4
$20K Buy
+439
New +$20.6K 0.01% 509

Other funds holding LMAT

Benjamin Edwards Inc's LMAT Position: Q2 2023 in Review

Benjamin Edwards Inc sold out of LeMaitre Vascular (LMAT) in Q2 2023, closing a stake of 1,068 shares — an estimated $55K sold.

Benjamin Edwards Inc first reported a position in LMAT in Q4 2022 and held it in 2 quarters. The position peaked at $55K in Q1 2023. 212 funds tracked by Wall St. Rank hold LMAT as of Q2 2023.

  • Benjamin Edwards Inc reported no remaining LeMaitre Vascular position as of Q2 2023 after selling out during the quarter.
  • Benjamin Edwards Inc sold 1,068 LeMaitre Vascular shares in Q2 2023, an estimated $55K.
  • Benjamin Edwards Inc first reported a position in LeMaitre Vascular in Q4 2022 and held it in 2 quarters.
  • Benjamin Edwards Inc's LeMaitre Vascular position peaked at $55K in Q1 2023.
  • 212 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2023.

Based on Benjamin Edwards Inc's 13F filing for Q2 2023, filed 15 Aug 2023.